Skip to content
value.today

Lumicell Diagnostics, Inc.

🇺🇸 Waltham, Massachusetts, USABiotechnologyFounded 2008
Total raised
$331 M
9 rounds on record
Latest round
$198 M
Apr 2025
First round on record
May 2011
Today
Private
No later event on record

Funding rounds

9 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Lumicell Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2025$198 MNo. 9$50 to $250 million

Lumicell Diagnostics, Inc.: Raise no. 9, Apr 2025

Investors in this round

64 investors had bought by the notice of May 6, 2025: 64 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$198 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$395,617
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Howard Hechler · Executive Officer, Director
  • Jorge Ferrer · Executive Officer
  • Andrey J. Zarur · Director
  • Carlos J. Gonzalez · Director
  • David J. Furneaux · Director
  • Elon J. Boms · Director
  • James J. Alecxih · Director
  • Kevin J. Krenitsky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Network 1 Financial Securities Inc. (CRD 13577) · Red Bank, New JerseySold in all US states

Remarks in the notice

  • On the amounts: “The offering includes securities to be acquired upon the exchange of other securities and the exchange value is not currently known or knowable. The amount sold includes a good faith valuation of the non-cash consideration received.”

Signed by Howard Hechler, President. Source: SEC Form D, newest notice filed May 6, 2025. Read the notice at the SEC.

equitySEC
Jul 2024$3 MNo. 8$2 to $10 million

Lumicell Diagnostics, Inc.: Raise no. 8, Jul 2024

Investors in this round

11 investors had bought by the notice of Jul 25, 2024: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $12 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Howard Hechler · Executive Officer
  • Jorge Ferrer · Executive Officer
  • Andrey Zarur · Director
  • Cosimo Fiorenza · Director
  • David Furneaux · Director
  • Elon Boms · Director
  • Kevin Krenitsky · Director
  • Mike Ruettgers · Director
  • W. David Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Network 1 Financial Securities Inc. (CRD 13577) · Red Bank, New JerseySold in all US states

Remarks in the notice

  • On the amounts: “The offering includes securities to be acquired upon the exchange of other securities.”

Signed by Howard Hechler, President. Source: SEC Form D, newest notice filed Jul 25, 2024. Read the notice at the SEC.

equity, debtSEC
Feb 2024$2 MNo. 7$2 to $10 million

Lumicell Diagnostics, Inc.: Raise no. 7, Feb 2024

Investors in this round

6 investors had bought by the notice of Mar 8, 2024: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Howard Hechler · Executive Officer
  • Jorge Ferrer · Executive Officer
  • Andrey Zarur · Director
  • Cosimo Fiorenza · Director
  • David Furneaux · Director
  • Elon Boms · Director
  • Kevin Krenitsky · Director
  • Mike Ruettgers · Director
  • W. David Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The offering includes securities to be acquired upon the exchange of other securities.”

Signed by Howard Hechler, President. Source: SEC Form D, newest notice filed Mar 8, 2024. Read the notice at the SEC.

equity, debt, optionsSEC
Jul 2023$76 MNo. 6$50 to $250 million

Lumicell Diagnostics, Inc.: Raise no. 6, Jul 2023

Investors in this round

47 investors had bought by the notice of Jul 26, 2023: 47 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$76 M of $110 M offered; $34 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kevin David Hershberger · Executive Officer, Director
  • Andrey David Zarur · Director
  • Cosimo David Fiorenza · Director
  • David David Furneaux · Director
  • Kevin David Krenitsky · Director
  • Michael David Ruettgers · Director
  • Moungi David Bawendi · Director
  • Ralph David Weissleder · Director
  • W. David Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Network Financial Securities Inc. (CRD 13577) · Red Bank, New JerseySold in all US states

Remarks in the notice

  • On fees: “no commissions earned or paid yet”
  • On the amounts: “Amounts offered and sold include $62,204,321 from conversion of convertible notes; Amount sold includes $2,273,076 in warrants”

Signed by Kevin Hershberger, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 26, 2023. Read the notice at the SEC.

equity, optionsSEC
Dec 2018$20 MNo. 5$10 to $50 million

Lumicell Diagnostics, Inc.: Raise no. 5, Dec 2018

Investors in this round

25 investors had bought by the notice of Dec 20, 2018: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $35 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey David Zarur · Executive Officer, Director
  • Kelly David Londy · Executive Officer, Director
  • Kevin David Hershberger · Executive Officer
  • W. David Lee · Executive Officer, Director
  • David David Furneaux · Director
  • Kevin David Krenitsky · Director
  • Michael David Ruettgers · Director
  • Moungi David Bawendi · Director
  • Ralph David Weissleder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin Hershberger, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 20, 2018. Read the notice at the SEC.

equitySEC
Jun 2017$21 MNo. 4$10 to $50 million

Lumicell Diagnostics, Inc.: Raise no. 4, Jun 2017

Investors in this round

24 investors had bought by the notice of Oct 18, 2017: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $27 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey David Zarur · Executive Officer, Director
  • Kelly David Londy · Executive Officer, Director
  • W. David Lee · Executive Officer, Director
  • David David Furneaux · Director
  • James David Schuermann · Director
  • Kevin David Krenitsky · Director
  • Moungi David Bawendi · Director
  • Ralph David Weissleder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold in item 13 and number of investors in item 14 includes $3,300,009 from one non-US investor.”

Signed by Kelly Londy, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 18, 2017. Read the notice at the SEC.

equitySEC
Apr 2016$7 MNo. 3$2 to $10 million

Lumicell Diagnostics, Inc.: Raise no. 3, Apr 2016

Investors in this round

10 investors had bought by the notice of May 4, 2016: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $10 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey David Zarur · Executive Officer, Director
  • W. David Lee · Executive Officer, Director
  • David David Furneaux · Director
  • James David Schuermann · Director
  • Kevin David Krenitsky · Director
  • Moungi David Bawendi · Director
  • Ralph David Weissleder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by W. David Lee, President & CEO. Source: SEC Form D, newest notice filed May 4, 2016. Read the notice at the SEC.

equity, optionsSEC
Dec 2013$2 MNo. 2Under $2 million

Lumicell Diagnostics, Inc.: Raise no. 2, Dec 2013

Investors in this round

7 investors had bought by the notice of Feb 25, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey David Zarur · Executive Officer, Director
  • W. David Lee · Executive Officer, Director
  • David David Furneaux · Director
  • Moungi David Bawendi · Director
  • Ralph David Weissleder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by W. David Lee, President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Feb 25, 2014. Read the notice at the SEC.

equitySEC
May 2011$3 MNo. 1$2 to $10 million

Lumicell Diagnostics, Inc.: Raise no. 1, May 2011

Investors in this round

4 investors had bought by the notice of Jun 1, 2011: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrey David Zarur · Executive Officer, Director
  • W. David Lee · Executive Officer, Director
  • William D. Johnson · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by W. David Lee, President & CEO. Source: SEC Form D, newest notice filed Jun 1, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Lumicell Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2025).

    SEC Form D · May 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2025

That is all the official record says: Lumicell Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Lumicell Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 9 rounds above had up to 64 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Lumicell Diagnostics, Inc.
NameRoleNamed in
Howard HechlerExecutive officerMay 2025
Jorge FerrerExecutive officerMay 2025
Kevin David HershbergerExecutive officerJul 2023
Andrey David ZarurExecutive officerDec 2018
Kelly David LondyExecutive officerDec 2018
W. David LeeExecutive officerDec 2018
William D. JohnsonExecutive officerJun 2011
Andrey J. ZarurDirectorMay 2025
Carlos J. GonzalezDirectorMay 2025
David J. FurneauxDirectorMay 2025
Elon J. BomsDirectorMay 2025
Howard HechlerDirectorMay 2025
James J. AlecxihDirectorMay 2025
Kevin J. KrenitskyDirectorMay 2025
Andrey ZarurDirectorJul 2024
Cosimo FiorenzaDirectorJul 2024
David FurneauxDirectorJul 2024
Elon BomsDirectorJul 2024
Kevin KrenitskyDirectorJul 2024
Mike RuettgersDirectorJul 2024
W. David LeeDirectorJul 2024
Andrey David ZarurDirectorJul 2023
Cosimo David FiorenzaDirectorJul 2023
David David FurneauxDirectorJul 2023
Kevin David HershbergerDirectorJul 2023
Kevin David KrenitskyDirectorJul 2023
Michael David RuettgersDirectorJul 2023
Moungi David BawendiDirectorJul 2023
Ralph David WeisslederDirectorJul 2023
Kelly David LondyDirectorDec 2018
James David SchuermannDirectorOct 2017